All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F17%3AA1801R84" target="_blank" >RIV/61988987:17110/17:A1801R84 - isvavai.cz</a>

  • Alternative codes found

    RIV/00843989:_____/17:E0106423

  • Result on the web

    <a href="http://dx.doi.org/10.1093/annonc/mdx096" target="_blank" >http://dx.doi.org/10.1093/annonc/mdx096</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1093/annonc/mdx096" target="_blank" >10.1093/annonc/mdx096</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  • Original language description

    Multiple myeloma (MM) accounts for 1% of all cancers and ?10% of all haematological malignancies. The incidence in Europe is 4.5-6.0/100 000/year with a median age at diagnosis of 72 years; the mortality is 4.1/100 000/year [1]. Almost all patients with MM evolve from an asymptomatic pre-malignant stage termed monoclonal gammopathy of undetermined significance (MGUS). MGUS progresses to MM at a rate of 1% per year. In some patients, an intermediate asymptomatic but more advanced pre-malignant stage termed smouldering (or indolent) MM (SMM) can be recognised. SMM progresses to myeloma at a rate of 10% per year over the first 5 years following diagnosis, 3% per year over the following 5 years, and 1.5% per year thereafter [2].

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    ANNALS OF ONCOLOGY

  • ISSN

    0923-7534

  • e-ISSN

    1569-8041

  • Volume of the periodical

    28

  • Issue of the periodical within the volume

    4/2017

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

    52-61

  • UT code for WoS article

    000405408400004

  • EID of the result in the Scopus database

    2-s2.0-85028812955